The effect of using different contrast agents in CT scan on radiation dose during radiotherapy

Phase 4

• Conditions: Malignant neoplasm of prostate; Prostate Cancer.

• Registration Number: IRCT20190814044528N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

Prostate cancer patients who are referred to the CT scan ward for CT imaging and don't have the exclusion criteria

Exclusion Criteria

Patients under 18 years old
Patients with kidney problems
Diabetic patients
Patients with a history of asthma and immunological allergies
People who had allergy to the use of contrast agents in the past

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Radiation dose of the patient. Timepoint: After CT imaging with injection of contrast material. Method of measurement: Radiotherapy treatment planning software (TPS).